Bavarian Nordic A/S (BVNRY)
8.648
+0.27
(+3.25%)
USD |
OTCM |
May 17, 14:50
Bavarian Nordic Market Cap: 2.022B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 1.958B |
May 15, 2024 | 1.933B |
May 14, 2024 | 1.880B |
May 13, 2024 | 1.857B |
May 10, 2024 | 1.806B |
May 09, 2024 | 1.792B |
May 08, 2024 | 1.817B |
May 07, 2024 | 1.810B |
May 06, 2024 | 1.796B |
May 03, 2024 | 1.742B |
May 02, 2024 | 1.686B |
May 01, 2024 | 1.686B |
April 30, 2024 | 1.694B |
April 29, 2024 | 1.695B |
April 26, 2024 | 1.648B |
April 25, 2024 | 1.618B |
April 24, 2024 | 1.672B |
April 23, 2024 | 1.672B |
April 22, 2024 | 1.663B |
April 19, 2024 | 1.626B |
April 18, 2024 | 1.618B |
April 17, 2024 | 1.645B |
April 16, 2024 | 1.670B |
April 15, 2024 | 1.694B |
April 12, 2024 | 1.700B |
Date | Value |
---|---|
April 11, 2024 | 1.700B |
April 10, 2024 | 1.678B |
April 09, 2024 | 1.702B |
April 08, 2024 | 1.694B |
April 05, 2024 | 1.727B |
April 04, 2024 | 1.742B |
April 03, 2024 | 1.831B |
April 02, 2024 | 1.816B |
April 01, 2024 | 1.726B |
March 28, 2024 | 1.737B |
March 27, 2024 | 1.744B |
March 26, 2024 | 1.743B |
March 25, 2024 | 1.729B |
March 22, 2024 | 1.765B |
March 21, 2024 | 1.789B |
March 20, 2024 | 1.779B |
March 19, 2024 | 1.785B |
March 18, 2024 | 1.775B |
March 15, 2024 | 1.840B |
March 14, 2024 | 1.840B |
March 13, 2024 | 1.894B |
March 12, 2024 | 1.906B |
March 11, 2024 | 1.899B |
March 08, 2024 | 1.964B |
March 07, 2024 | 1.912B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
674.14M
Minimum
Mar 30 2020
4.041B
Maximum
Aug 04 2022
1.977B
Average
1.934B
Median
Dec 21 2023
Market Cap Benchmarks
Genmab A/S | 19.35B |
Ascendis Pharma A/S | 6.849B |
Galecto Inc | 16.75M |
Evaxion Biotech AS | 19.40M |
IO Biotech Inc | 91.57M |
Market Cap Related Metrics
PE Ratio | 13.91 |
PS Ratio | 2.061 |
PEG Ratio | 0.0625 |
Price to Book Value | 1.374 |
Price to Free Cash Flow | 13.36 |
Price | 8.648 |
Earnings Yield | 7.19% |
Operating PE Ratio | 13.71 |
Normalized PE Ratio | 14.03 |